Peptides
Evidence: moderate_human
Kisspeptin-10 is the 10-amino acid C-terminal fragment of the kisspeptin family that signals directly to GnRH neurons through the kisspeptin receptor (KISS1R/GPR54), triggering GnRH release into the portal circulation. This stimulates LH and FSH secretion from anterior pituitary gonadotrophs. In men, intravenous kisspeptin-10 produces rapid dose-dependent LH rises (4.1 to 12.4 IU/L at 1 mcg/kg within 30 minutes), increases LH pulse frequency and amplitude, and subsequently elevates testosterone through the HPG axis.
Standard: Research indicates 1-10 mcg/kg via subcutaneous injection or IV bolus for acute HPG axis stimulation.
Maintenance: Research indicates dosing remains experimental with no established maintenance protocol.
Administration: subcutaneousintravenous
Timing: Morning dosing preferred for testosterone optimization. Can be used acutely before sexual activity.
Duration: Short-term use only. Continuous kisspeptin administration may cause tachyphylaxis (desensitization) of the HPG axis.
Kisspeptin-10 is one of the most physiological approaches to HPG axis stimulation — it works upstream of GnRH, preserving the entire natural hormonal cascade. It has shown promise for stimulating LH and testosterone in men and for treating functional hypothalamic amenorrhea in women. The short half-life and potential for desensitization limit its practical utility for chronic testosterone optimization. Most promising as a diagnostic tool and for acute use. Research is ongoing into longer-acting kisspeptin analogs.
Research-grade supplier. Extremely limited compounding pharmacy availability. Very short half-life requires precise timing.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →